AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,263,680 | +188.4% | 204,119 | +217.5% | 0.01% | +150.0% |
| Q4 2022 | $784,981 | +7.2% | 64,290 | -8.2% | 0.00% | 0.0% |
| Q3 2022 | $732,000 | +115.3% | 70,069 | +97.0% | 0.00% | 0.0% |
| Q3 2021 | $340,000 | +144.6% | 35,568 | +146.2% | 0.00% | +100.0% |
| Q2 2021 | $139,000 | -46.1% | 14,449 | -44.7% | 0.00% | -50.0% |
| Q1 2021 | $258,000 | -40.4% | 26,139 | -14.7% | 0.00% | -33.3% |
| Q3 2020 | $433,000 | +177.6% | 30,658 | +197.2% | 0.01% | +200.0% |
| Q2 2020 | $156,000 | – | 10,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |